Skip to main content
SpringerLink
Log in

Clinical Applications of Hepatobiliary MR Contrast Agents

  • Chapter
  • First Online:
Abdomen and Thoracic Imaging

  • 1767 Accesses

Abstract

Modern hepatocellular-specific MR contrast agents such as gadoxetic acid are an important adjunct to conventional extracellular contrast material in MRI examinations of the liver. They allow not only evaluation of vascular structures and early dynamic contrast kinetics but are also able to determine the presence or absence of functioning hepatocytes. In addition, the high biliary excretion rate of 50% allows a true T1 cholangiopancreatography phase with improved characterization of biliary abnormalities and leaks.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Vogl TJ, Kummel S, Hammerstingl R et al (1996) Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. Radiology 200(1):59–67

    PubMed  CAS  Google Scholar 

  2. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ (2005) Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 40(11):715–724

    Article  PubMed  Google Scholar 

  3. Van Beers BE, Pastor CM, Hussain HK (2012) Primovist, Eovist: what to expect? J Hepatol 57(2):421–429

    Article  PubMed  Google Scholar 

  4. Feuerlein S, Boll DT, Gupta RT, Ringe KI, Marin D, Merkle EM (2011) Gadoxetate disodium-enhanced hepatic MRI: dose-dependent contrast dynamics of hepatic parenchyma and portal vein. AJR Am J Roentgenol 196(1):W18–W24

    Article  PubMed  Google Scholar 

  5. Colagrande S, Mazzoni LN, Mazzoni E, Pradella S (2012) Effects of gadoxetic acid on quantitative diffusion-weighted imaging of the liver. J Magn Reson Imaging

    Google Scholar 

  6. Choi JS, Kim MJ, Choi JY, Park MS, Lim JS, Kim KW (2010) Diffusion-weighted MR imaging of liver on 3.0-Tesla system: effect of intravenous administration of gadoxetic acid disodium. Eur Radiol 20(5):1052–1060

    Article  PubMed  Google Scholar 

  7. Ringe KI, Gupta RT, Brady CM et al (2010) Respiratory-triggered three-dimensional T2-weighted MR cholangiography after injection of gadoxetate disodium: is it still reliable? Radiology 255(2):451–458

    Article  PubMed  Google Scholar 

  8. Kim KA, Kim MJ, Park MS et al (2010) Optimal T2-weighted MR cholangiopancreatographic images can be obtained after administration of gadoxetic acid. Radiology 256(2):475–484

    Article  PubMed  Google Scholar 

  9. Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29(6):1725–1748

    Article  PubMed  Google Scholar 

  10. Asbach P, Warmuth C, Stemmer A et al (2008) High spatial resolution T1-weighted MR imaging of liver and biliary tract during uptake phase of a hepatocyte-specific contrast medium. Invest Radiol 43(11):809–815

    Article  PubMed  Google Scholar 

  11. Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230(1):266–275

    Article  PubMed  Google Scholar 

  12. Tamada T, Ito K, Yamamoto A et al (2011) Hepatic hemangiomas: evaluation of enhancement patterns at dynamic MRI with gadoxetate disodium. AJR Am J Roentgenol 196(4):824–830

    Article  PubMed  Google Scholar 

  13. Gupta RT, Marin D, Boll DT et al (2012) Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium. Eur J Radiol 81(10):2457–2462

    Article  PubMed  Google Scholar 

  14. Motosugi U, Ichikawa T, Onohara K et al (2011) Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Invest Radiol 46(6):359–365

    Article  PubMed  Google Scholar 

  15. Goshima S, Kanematsu M, Watanabe H et al (2010) Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR Am J Roentgenol 195(4):941–946

    Article  PubMed  Google Scholar 

  16. Hussain SM, Terkivatan T, Zondervan PE et al (2004) Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 24(1):3–17; discussion 8–9

    Article  PubMed  Google Scholar 

  17. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C (1999) Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 23(12):1441–1454

    Article  PubMed  CAS  Google Scholar 

  18. Zech CJ, Grazioli L, Breuer J, Reiser MF, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Invest Radiol 43(7):504–511

    Article  PubMed  Google Scholar 

  19. Trotter JF, Everson GT (2001) Benign focal lesions of the liver. Clin Liver Dis 5(1):17–42, v

    Google Scholar 

  20. Grazioli L, Federle MP, Brancatelli G, Ichikawa T, Olivetti L, Blachar A (2001) Hepatic adenomas: imaging and pathologic findings. Radiographics 21(4):877–892; discussion 92–4

    Article  PubMed  CAS  Google Scholar 

  21. Colli A, Fraquelli M, Massironi S, Colucci A, Paggi S, Conte D (2007) Elective surgery for benign liver tumours. Cochrane Database Syst Rev 1, CD005164

    PubMed  Google Scholar 

  22. Denecke T, Steffen IG, Agarwal S et al (2012) Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol 22(8):1769–1775

    Article  PubMed  Google Scholar 

  23. Grazioli L, Bondioni MP, Haradome H et al (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262(2):520–529

    Article  PubMed  Google Scholar 

  24. Goodwin MD, Dobson JE, Sirlin CB, Lim BG, Stella DL (2011) Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents. Radiographics 31(6):1547–1568

    Article  PubMed  Google Scholar 

  25. Choi JY, Choi JS, Kim MJ et al (2010) Detection of hepatic hypovascular metastases: 3D gradient echo MRI using a hepatobiliary contrast agent. J Magn Reson Imaging 31(3):571–578

    Article  PubMed  Google Scholar 

  26. Kim A, Lee CH, Kim BH et al (2012) Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a “defect” on the hepatobiliary phase. Eur J Radiol 81(12):3998–4004

    Article  PubMed  Google Scholar 

  27. Ha S, Lee CH, Kim BH et al (2012) Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the “target sign” a common finding? Magn Reson Imaging 30(8):1083–1090

    Article  PubMed  Google Scholar 

  28. Sofue K, Tsurusaki M, Tokue H, Arai Y, Sugimura K (2011) Gd-EOB-DTPA-enhanced 3.0 T MR imaging: quantitative and qualitative comparison of hepatocyte-phase images obtained 10 min and 20 min after injection for the detection of liver metastases from colorectal carcinoma. Eur Radiol 21(11):2336–2343

    Article  PubMed  Google Scholar 

  29. Hussain SM, Reinhold C, Mitchell DG (2009) Cirrhosis and lesion characterization at MR imaging. Radiographics 29(6):1637–1652

    Article  PubMed  Google Scholar 

  30. Sano K, Ichikawa T, Motosugi U et al (2011) Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. Radiology 261(3):834–844

    Article  PubMed  Google Scholar 

  31. Kondo F (2011) Assessment of stromal invasion for correct histological diagnosis of early hepatocellular carcinoma. Int J Hepatol 2011:241652

    PubMed  Google Scholar 

  32. Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT—initial observations. Radiology 234(2):468–478

    Article  PubMed  Google Scholar 

  33. Saito K, Kotake F, Ito N et al (2005) Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase. Magn Reson Med Sci 4(1):1–9

    PubMed  Google Scholar 

  34. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D (2007) Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 17(10):2519–2530

    Article  PubMed  Google Scholar 

  35. Kitao A, Zen Y, Matsui O et al (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging—correlation with molecular transporters and histopathologic features. Radiology 256(3):817–826

    Article  PubMed  Google Scholar 

  36. Yamamoto A, Tamada T, Sone T, Higashi H, Yamashita T, Ito K (2010) Gd-EOB-DTPA-enhanced magnetic resonance imaging findings of nondiffuse fatty change of the liver. J Comput Assist Tomogr 34(6):868–873

    Article  PubMed  Google Scholar 

  37. Fayad LM, Holland GA, Bergin D et al (2003) Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography. J Magn Reson Imaging 18(4):449–460

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Medical Imaging, University of Virginia Medical Center, Charlottesville, VA, 800170, 22908, USA

    Antoine Wadih M.D. & Sebastian Feuerlein M.D.

Authors
  1. Antoine Wadih M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sebastian Feuerlein M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sebastian Feuerlein M.D. .

Editor information

Editors and Affiliations

  1. Department of Bioengineering, University of Louisville, Louisville, Kentucky, USA

    Ayman S. El-Baz

  2. University of Cagliari, Cagliari, Italy

    Luca Saba

  3. Biomedical Technologies, Inc Idaho State University (Affiliated), Roseville, California, USA

    Jasjit Suri

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Wadih, A., Feuerlein, S. (2014). Clinical Applications of Hepatobiliary MR Contrast Agents. In: El-Baz, A., Saba, L., Suri, J. (eds) Abdomen and Thoracic Imaging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8498-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8498-1_13

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-8497-4

  • Online ISBN: 978-1-4614-8498-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation